Notice

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

Updates regarding government operating status and resumption of normal operations can be found at USA.gov.

HIV Drug Formulation Development and Manufacturing Services

This service program supports the development and manufacture, of a wide variety of pharmaceutical dosage formulations, including tablets, capsules, semi-solid preparations, injectibles, and sustained-release products. If requested, manufacturing can be done under GMP.

Main Areas of Focus

  • To fill specific gaps in an investigator’s drug development plan as they advance their product towards clinical investigation
  • To help investigators obtain data to get additional funding
  • To help with prospective partnerships
  • To help getting regulatory permission to continue

Support Services

  • Characterization of physical and chemical properties of bulk drug substances targeted for formulation development
  • Formulation development to enhance drug solubility, improve bioavailability, enhance drug stability, deliver to target tissues, and treat specific patient populations
  • Stability and release properties of formulations in analytical and in vitro assays
  • Long-term stability studies of manufactured formulations
  • Formulations can be manufactured, packaged, labeled, and shipped under GMP guidelines. 

Investigators seeking these services receive no funding from NIAID, but instead receive products or information generated by NIAID-funded contractors on their behalf.

Who Can Use This Resource

  • Product must be defined and of known chemical structure
  • Investigator must have preliminary data to support the continued development of product

How To Get Started

Content last reviewed on November 17, 2017